Stockhead TV
Check out the latest Ausbiotech news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Stockhead TV
Long Shortz with AROA Biosurgery: A chance at a smoother recovery from a Mastectomy? Thanks Enivo
Long Shortz with Optiscan: Optiscan optimises AI in its fight against GI baddies
News
In Case You Missed It: R&D refunds for drug developers and a major uranium merger
News
Closing Bell: Friday takes a bite out of ASX, even as biotech and lithium small caps run amok
News
ASX Small Cap Lunch Wrap: Benchmark higher as Chimeric stock finds huge support ‘cos even investors hate cancer
News
Yamaha is making boats with wood 5x stronger than steel… But Aussie spinifex cellulose nanofibre is tougher, mate
News
ASX Small Caps and IPO Weekly Wrap: ASX biotechs make hay as bond markets boil
News
Closing Bell: Small cap biopharma injects a little excitement as ASX finally finds a Thursday butt to kick
Health & Biotech
Unicorns Podcast: Control Bionics (ASX CBL) leading the world in life-changing technology
News
After Neuren’s success, which other ASX health stocks are knocking on the US FDA door?
News
Top 10 at 10: Which gold junior is up 120pc after signing a US$300m funding facility?
News
Boost for ASX healthcare sector as Neuren gets US FDA approval for drug to treats Rett Syndrome
Health & Biotech
Vida Ventures MD says it’s a rosy outlook for biotech investment in Australia in the long run
Investor Guides
Investor Guide: Health & Biotech FY2023
Health & Biotech
Australia’s biotech industry is thriving, with ASX-listed companies up 19% since 2019
Experts
ScoPo’s Powerplays: ASX health stocks finish reporting season in pretty strong shape
News
Low-cost ETFs: NAB teams with iShares to launch multi-asset and megatrend ETFs
News
We asked 5,000 Aussies where they’ll stash cash over the next 2 years and it got weird
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Experts
ScoPo’s Powerplays: Business as usual for ASX health stocks plus… some good news!
Health & Biotech
MGC Pharma results provides real hope for Alzheimer’s sufferers
Health & Biotech
Dr Boreham’s Crucible: A Pfizer takeover could make Resapp a genuine chestbeater
Health & Biotech
Fighting Back: 3 ASX cancer stocks giving hope in a leading cause of death
Experts
SocPo’s Powerplays: A few healthcare gems among the carnage
Experts
ScoPo’s Powerplays: Healthcare’s game is off, but a comeback is possible
Health & Biotech
Stock Insiders: Veteran biotech player joins EZZ on journey to fully integrated life sciences company
News
Closing Bell: The ASX lifts with all sectors finishing in the green
News
Closing Bell: ASX suffers biggest one day fall in 16 months, tech sector completely smoked
Health & Biotech
Advanced Human Imaging and PainChek gain after taking their next steps internationally
IPO Watch
IPO Watch: Mosquito disease fighter Island Pharmaceuticals doubles on debut
Health & Biotech
Bard1 caps off 600pc+ in 6 weeks proving it can detect another type of cancer
Health & Biotech
Health Kick: Renowned biotech entrepreneur Paul Hopper on raising money, picking biotech winners and his latest ASX venture
Experts
Expert view: Here’s what investors are getting wrong about Australian health stocks
Health & Biotech
Megan Baldwin just joined the board of this ASX biotech stock
Health & Biotech
Cancer diagnostics stock Bard1 gains another 40pc with more positive data
Health & Biotech
Bard1 Life Sciences shares double after ovarian cancer detection tech passes test with flying colours
Experts
MoneyTalks: This biotech focused fund explains why it invested $15m in these 2 ASX stocks
Stockhead TV
CAR T cell therapy is driving better cancer treatment outcomes
Health & Biotech
Orthocell jumps again after dental membrane approved in USA
Health & Biotech
Check Up: Rhythm Biosciences shares just keep on soaring
News
IPO Watch: Two gold explorers lead a pack of ASX debuts in January
Health & Biotech
Who else on the ASX joins Mesoblast in the fight against ARDS and where are they at?
Health & Biotech
Orthocell shares spike after more positive clinical data from its nerve regeneration study
Health & Biotech
Superbugs will kill 22,000 Australians annually by 2040; but these stocks are trying to stop that
News
Weekly ASX Small Cap Wrap: Who’s finally found their greatest gift this week?
Health & Biotech
Rhythm Biosciences proves its colorectal cancer test is for real; shares up nearly 600pc in 8 months
Health & Biotech
Health Kick: Investors eye AdAlta’s fibrosis fighting i-body platform
Load More